No proof for retinal amyloid after oral curcumin in amyloid confirmed AD cases

Jurre den Haan, Frederique J. Hart de Ruyter, Benjamin Lochocki, Maurice A.G.M. Kroon, E. Marleen Kemper, Charlotte E. Teunissen, Bart van Berckel, Philip Scheltens, Jeroen J. Hoozemans, Aleid van de Kreeke, Frank D. Verbraak, Johannes F. de Boer, Femke H. Bouwman
doi: https://doi.org/10.1101/2021.10.07.21264420

Article usage

Article usage: October 2021 to November 2024

AbstractFullPdf
Oct 20214419125
Nov 2021160771
Dec 202175229
Jan 202251615
Feb 202252039
Mar 202241416
Apr 202260025
May 202234826
Jun 202283915
Jul 202242107
Aug 2022219536
Sep 2022223720
Oct 2022751917
Nov 202264311
Dec 202232713
Jan 202336411
Feb 20232775
Mar 202328138
Apr 202329819
May 20231364
Jun 20231272
Jul 2023988
Aug 202318167
Sep 202315125
Oct 202313610
Nov 202319195
Dec 20231789
Jan 2024754
Feb 20241683
Mar 2024755
Apr 2024677
May 2024161515
Jun 202416815
Jul 20247311
Aug 202416719
Sep 202419813
Oct 2024844
Nov 202413513
Back to top
Posted October 11, 2021.
Download PDF
Data/Code
Email
No proof for retinal amyloid after oral curcumin in amyloid confirmed AD cases
Jurre den Haan, Frederique J. Hart de Ruyter, Benjamin Lochocki, Maurice A.G.M. Kroon, E. Marleen Kemper, Charlotte E. Teunissen, Bart van Berckel, Philip Scheltens, Jeroen J. Hoozemans, Aleid van de Kreeke, Frank D. Verbraak, Johannes F. de Boer, Femke H. Bouwman
medRxiv 2021.10.07.21264420; doi: https://doi.org/10.1101/2021.10.07.21264420
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area